000			02162 a2200613 4500
005			20250515081308.0
264		0	_c20071226
008			200712s 0 0 eng d
022			_a0006-4971
024	7		_a10.1182/blood-2007-02-076075 _2doi
040			_aNLM _beng _cNLM
100	1		_aDaniel, Dylan
245	0	0	_aCooperation of the proapoptotic receptor agonist rhApo2L/TRAIL with the CD20 antibody rituximab against non-Hodgkin lymphoma xenografts. _h[electronic resource]
260			_bBlood _cDec 2007
300			_a4037-46 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal _xpharmacology
650	0	4	_aAntibodies, Monoclonal, Murine-Derived
650	0	4	_aAntibody Formation _xdrug effects
650	0	4	_aAntineoplastic Agents _xagonists
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aComplement System Proteins _xmetabolism
650	0	4	_aDrug Resistance, Neoplasm _xdrug effects
650	0	4	_aDrug Synergism
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aKiller Cells, Natural _xmetabolism
650	0	4	_aLymphocyte Depletion
650	0	4	_aLymphoma, Non-Hodgkin _xdrug therapy
650	0	4	_aMice
650	0	4	_aMice, Inbred ICR
650	0	4	_aMice, SCID
650	0	4	_aReceptors, TNF-Related Apoptosis-Inducing Ligand _xantagonists & inhibitors
650	0	4	_aReceptors, Tumor Necrosis Factor _xantagonists & inhibitors
650	0	4	_aRecombinant Proteins _xagonists
650	0	4	_aRituximab
650	0	4	_aTNF-Related Apoptosis-Inducing Ligand _xagonists
650	0	4	_aTransplantation, Heterologous
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aYang, Becky
700	1		_aLawrence, David A
700	1		_aTotpal, Klara
700	1		_aBalter, Inessa
700	1		_aLee, Wyne P
700	1		_aGogineni, Alvin
700	1		_aCole, Mary J
700	1		_aYee, Sharon Fong
700	1		_aRoss, Sarajane
700	1		_aAshkenazi, Avi
773	0		_tBlood _gvol. 110 _gno. 12 _gp. 4037-46
856	4	0	_uhttps://doi.org/10.1182/blood-2007-02-076075 _zAvailable from publisher's website
999			_c17254159 _d17254159